Home › Overweight › Ohio › Cleveland
Overweight clinical trials in Cleveland, OH
5 studies for Overweight are looking for participants at sites in and around Cleveland (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
RecruitingPhase 3
- Cleveland Clinic, Cleveland
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RecruitingPhase 3
- Velocity Clinical Research - Cleveland, Beachwood · 10 mi away
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
RecruitingPhase 3
- AURORA-1 Clinical Site, Cleveland
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
RecruitingPhase 3
- AURORA-2 Clinical Site, Cleveland
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
RecruitingPhase 3
- Kailera Clinical Site, Cleveland
Overweight trials in other cities
- Houston, TX33 studies
- San Antonio, TX33 studies
- Chicago, IL28 studies
- Orlando, FL25 studies
- Las Vegas, NV23 studies
- Miami, FL23 studies
- Dallas, TX20 studies
- Atlanta, GA20 studies
- Jacksonville, FL19 studies
- Washington, DC19 studies
- New York City, NY19 studies
- Austin, TX18 studies
Other studies in Cleveland
- Non-Small Cell Lung Cancer44 studies
- Cancer (all types)37 studies
- Breast Cancer35 studies
- Prostate Cancer34 studies
- Heart Failure33 studies
- Metastatic Cancer30 studies
- Ovarian Cancer28 studies
- Lung Cancer26 studies
- Colorectal Cancer24 studies
- Cardiovascular Disease22 studies
- Endometrial Cancer21 studies
- Acute Myeloid Leukemia20 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.